期刊文献+

基于网络药理学和分子对接探讨甘草防治阿尔茨海默病的分子机制 被引量:1

Molecular mechanism of Glycyrrhiza in prevention and treatment of Alzheimer’s disease based on network pharmacology and molecular docking
下载PDF
导出
摘要 目的运用网络药理学和分子对接技术探究甘草防治阿尔茨海默病(AD)的分子机制。方法通过中药系统药理学数据库与分析平台(TCMSP)筛选甘草活性成分,并利用有关数据库筛选AD相关靶点。以Cytoscape软件构建"药物-化合物-靶点"网络,并用分子对接验证有效成分与靶点亲和力。结果筛选出甘草64个活性成分和692个靶点,这些靶点与82个AD相关潜在靶点有较强相互作用,主要富集于神经活性配体受体相互作用、AD通路、钙信号通路、5-羟色胺能突触、cAMP信号通路等12条通路。分子对接结果显示甘草素、光甘草素和甘草宁O等化合物与关键靶点淀粉样前体蛋白(APP)、单胺氧化酶B(MAOB)、半胱天冬蛋白酶3(CASP3)、5-羟色胺转运体(SLC6A4)、乙酰胆碱酯酶(AchE)具有良好亲和力。结论甘草中异甘草素、甘草素等化合物可能通过作用于APP、CASP3、MAOB、SLC6A4、ACHE等靶点,介导5-羟色胺能突触通路,进而发挥防治AD作用。 Objective To explore the molecular mechanism of Glycyrrhiza in prevention and treatment of Alzheimer’s disease(AD)using network pharmacology and molecular docking.Methods The active components of Glycyrrhiza were screened by the Chinese Medicine System Pharmacology Database and Analysis Platform(TCMSP).AD-associated targets were screened using related databases.The drug-compound-target network was constructed by Cytoscape software,and the affinity between effective components and targets was verified by molecular docking.Results Sixty-four active components and 692 targets of Glycyrrhiza were screened.These targets had strong interaction with 82 potential ADassociated targets,mainly enriched in 12 pathways,such as neuroactive ligand-receptor interaction,AD pathway,calcium signaling,serotonergic synapse,cAMP signaling and so on.The molecular docking revealed that glycyrrhizin,glabrene and gancaonin O had good affinity with key targets amyloid precursor protein(APP),monoamine oxidase B(MAOB),caspase-3,SLC6 A4 and AchE.Conclusion Glycyrrhiza compounds such as isoliquiritigenin and glycyrrhizin may prevent and treat AD by acting on APP,caspase-3,MAOB,SLC6 A4 and AchE and mediating serotonergic synaptic pathway.
作者 马震东 黄晓风 朱思林 郭晋言 黄淑芸 陈倩文 杨春 杜以宽 MA Zhen-dong;HUANG Xiao-feng;ZHU Si-lin;GUO Jin-yan;HUANG Shu-yun;CHEN Qian-wen;YANG Chun;DU Yi-kuan(Key Laboratory of Stem Cell and Regeneration tissue Engineering,Guangdong Medical University,Dongguan 523000,China;Central Laboratory,Dongguan People's Hospital,Dongguan 523059,China)
出处 《广东医科大学学报》 2021年第6期684-692,共9页 Journal of Guangdong Medical University
基金 广东省自然科学基金面上项目(No.2020A1515010011,2021A1515011580) 广东省中医药局面上项目(No.20202101,20211216) 广东医科大学大学生创新创业训练项目(No.GDMU2019003,GDMU2019041,GDMU2020010,GDMU2020078) 2020年度省级和国家级大学生创新创业训练计划项目(No.202010571003,S202010571041)。
关键词 阿尔茨海默病 甘草 网络药理学 分子对接 Alzheimer’s disease Glycyrrhiza network pharmacology molecular docking
  • 相关文献

参考文献3

二级参考文献61

  • 1杨秀伟.何首乌醇提物对易老化小鼠肝脏和脑单胺氧化酶活性的影响[J].中国中药杂志,1996,21(1):48-49. 被引量:56
  • 2魏建宏,郭连魁.甘草对大鼠杏仁中央核肽能神经元年龄变化的影响[J].解剖学杂志,2006,29(2):209-212. 被引量:4
  • 3Venketasubramanian N, Young S, Tay SS, et al. Chinese medicine NeuroAiD efficacy stroke recovery-extension study (CHIMES-E study ): an observational multicenter study to investigate the longer-term efficacy of NeuroAiD in stroke recovery[J]. Cerebrovascular Diseases, 2013, 35suppl 1(1): 18-22.
  • 4Chen CLH, Young SHY, Gan HH, et al. Chinese Medicine Neuroaid Efficacy on Stroke Recovery: A Double-Blind, Placebo-Controlled, Randomized Study[J]. Stroke, 2013, 44 (8): 2093-2100.
  • 5Geon H K, Jieun E K, Sandy JR, et al. The Role of Oxidative Stress in Neurodegenerative Diseases[J]. Experimental Neurobiology, 2015, 24 (4) : 325-340.
  • 6Newland B, Newland H, Werner C, et al. Prospects for polymer therapeutics in Parkinson's disease and other neurodegenerative disorders[J]. Progress in Polymer Science, 2015, 44 : 79-112.
  • 7Loureiro J R, Oliveira C L, Silveira I. Unstable repeat expansions in neurodegenerative diseases: nucleocytoplasmic transport emerges on the scene[J]. Neurobiology of Aging, 2016, 39: 174-183.
  • 8Tajeddine N. How do reactive oxygen species and calcium trigger mitochondrial membrane permeabilisation?[J]. Biochimica et biophysica acta, 2016, (6): 1079-1088.
  • 9Rozpedek W, MarkiewiczL, Diehl JA, et al.The role of the adaptive stress response in the pathogenesis of neurodegenerative diseases, cancer and diabetes mellitus type 2 [J]. Pol Merkur Lekarski, 2015, 39 (234): 393-397.
  • 10Blaszezyk M, Boczarska-Jedynak M, Rudzinska M. Clinical variability of Juvenile Huntington's Disease phenotype[J]. Przegl Lek, 2015, 72 (7): 366-370.

共引文献14

同被引文献23

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部